Fig. 1From: Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?(Adapted from references 5 and 6)Complementary actions of basal insulin and GLP-1 analogue target the underlying pathophysiology of T2DMBack to article page